(Q73711280)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9303058%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Anti-tumor effects of local irradiation in combination with peritumoral administration of low doses of recombinant interleukin-2 (rIL-2) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9303058%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9303058%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

Jürgenliemk-Schulz IM

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9303058%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Renes IB

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9303058%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Rutgers DH

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9303058%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Bernsen MR

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9303058%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Den Otter W

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9303058%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Battermann JJ

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9303058%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9303058%20AND%20SRC:MED&resulttype=core&format=json

Radiation Oncology Investigations

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9303058%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9303058%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9303058%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

54-61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9303058%20AND%20SRC:MED&resulttype=core&format=json

Fractionation in radiotherapy

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281997%295%3A2%3C54%3A%3AAID-ROI3%3E3.0.CO%3B2-I

Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281997%295%3A2%3C54%3A%3AAID-ROI3%3E3.0.CO%3B2-I

A phase II study of high-dose continuous infusion interleukin-2 with lymphokine-activated killer cells in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281997%295%3A2%3C54%3A%3AAID-ROI3%3E3.0.CO%3B2-I

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281997%295%3A2%3C54%3A%3AAID-ROI3%3E3.0.CO%3B2-I

Tumour necrosis factor and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281997%295%3A2%3C54%3A%3AAID-ROI3%3E3.0.CO%3B2-I

Clinical and immunological effect of intravesical interleukin-2 on superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281997%295%3A2%3C54%3A%3AAID-ROI3%3E3.0.CO%3B2-I

Antitumor effect of locally injected low doses of recombinant human interleukin-2 in bovine vulval papilloma and carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281997%295%3A2%3C54%3A%3AAID-ROI3%3E3.0.CO%3B2-I

Optimal regimes for local IL-2 tumour therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281997%295%3A2%3C54%3A%3AAID-ROI3%3E3.0.CO%3B2-I

Apoptosis and programmed cell death in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281997%295%3A2%3C54%3A%3AAID-ROI3%3E3.0.CO%3B2-I

Activation of T lymphocytes for the adoptive immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281997%295%3A2%3C54%3A%3AAID-ROI3%3E3.0.CO%3B2-I

Interleukin-2. A review of its pharmacological properties and therapeutic use in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281997%295%3A2%3C54%3A%3AAID-ROI3%3E3.0.CO%3B2-I

Eradication of tumor cells after injection into immunized hosts compared with the eradication of tumor cells after transfer of immune peritoneal exudates into tumor-bearing recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281997%295%3A2%3C54%3A%3AAID-ROI3%3E3.0.CO%3B2-I

Immunotherapy for renal cell carcinoma: the era of interleukin-2-based treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281997%295%3A2%3C54%3A%3AAID-ROI3%3E3.0.CO%3B2-I

Identification of H-2Kb binding and immunogenic peptides from human papilloma virus tumour antigens E6 and E7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281997%295%3A2%3C54%3A%3AAID-ROI3%3E3.0.CO%3B2-I

Induction and characterization of cytotoxic T-lymphocytes recognizing a mutated p21ras peptide presented by HLA-A*0201.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281997%295%3A2%3C54%3A%3AAID-ROI3%3E3.0.CO%3B2-I

Synergistic antitumor activity of tumor-infiltrating lymphocytes, interleukin 2, and local tumor irradiation. Studies on the mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-6823%281997%295%3A2%3C54%3A%3AAID-ROI3%3E3.0.CO%3B2-I

10.1002/(SICI)1520-6823(1997)5:2<54::AID-ROI3>3.0.CO;2-I

21 January 2018

Identifiers

DOI

0 references

1 reference